Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,500 public trials 2,843 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT

NCT04173533

Conditions
Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +11 more
Locations
  • The Queen Elizabeth Hospital Birmingham, United Kingdom
  • University Hospital Bristol Bristol, United Kingdom
  • Addenbrooke's Hospital Cambridge, United Kingdom
  • University Hospital of Wales Cardiff, United Kingdom
View all 20 locations
View Trial Details
Completed

Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients

NCT01784068

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Lakes Research Miami Lakes, Florida, United States
  • H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Cancer Center of Kansas Wichita, Kansas, United States
View all 113 locations
View Trial Details
Completed

A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With AML or MDS

NCT02732184

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • Comprehensive Cancer Center at University of Michigan Ann Arbor, Michigan, United States
  • Washington University Medical School St Louis, Missouri, United States
  • University Hospitals Case Medical Center Cleveland, Ohio, United States
  • The Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Completed

COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies

NCT04354246

Conditions
Adnexal Diseases, Advanced Cancer, Blood Protein Disorders, +53 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Massachusetts General Hospital. Boston, Massachusetts, United States
  • START Midwest. Grand Rapids, Michigan, United States
  • The Ohio State University Comprehensive Cancer Center. Columbus, Ohio, United States
View Trial Details
Completed

A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

NCT02942290

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • Duplicate_University of Arizona Cancer Center - North Campus /ID# 154155 Tucson, Arizona, United States
  • The University of Chicago Medical Center /ID# 153673 Chicago, Illinois, United States
  • University of Maryland, Baltimore /ID# 153669 Baltimore, Maryland, United States
  • Tufts Medical Center /ID# 153672 Boston, Massachusetts, United States
View all 37 locations
View Trial Details
Completed

Dose-range Finding Treosulfan-based Conditioning

NCT01063647

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
Locations
  • Helsinki University Central Hospital Helsinki, Finland
  • Charité University Hospital Berlin Berlin, Germany
  • University Hospital Hamburg Eppendorf Hamburg, Germany
  • 5th Medical Clinic, Clinic North Nuremberg, Germany
View Trial Details
Completed

Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)

NCT01698905

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • USC Kenneth Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Indiana Blood and Marrow Institute Beech Grove, Indiana, United States
  • St Agnes Hospital Baltimore, Maryland, United States
  • University of Texas Medical Branch Galveston, Texas, United States
View all 62 locations
View Trial Details

Related conditions